A photo of Christopher Dandoy.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Associate Professor, UC Department of Pediatrics

513-803-7495

513-803-1969

Board Certified

About Me

Biography

I have always enjoyed caring for patients and their families, and I appreciate the unique bond that forms during treatment. But as a physician, I’ve experienced the devastating impact bloodstream infections can have on children. On more than one occasion, my team has successfully cured a child’s cancer using stem cell transplant, only to lose them later to a bloodstream infection.

As a result, my research focuses on identifying, testing and implementing clinical strategies to help improve outcomes after stem cell transplantation for malignancy. My clinical work compliments my research focus since I am the physician lead for the autologous stem cell transplant program, caring for many patients with leukemia. I prioritize patient safety, quality improvement, and the prevention of bloodstream infections and cardiopulmonary complications, such as pulmonary hypertension.

Cincinnati Magazine recognized me as a Top Doctor in 2019 and 2020. Also, our Cancer and Blood Diseases Institute Quality Improvement and Patient Safety team won the Ohio Patient Safety Institute’s Dr. Frank Dono Best Practice Award.

I am co-editor of the book Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation, published in 2017 by Springer. I’ve served in several local and national leadership roles, including the co-physician lead for the Solutions for Patient Safety (SPS) Pediatric Hematology-Oncology Central Line-Associated Bloodstream Infection (CLABSI) reduction collaboration.

I serve as the vice chair of the American Society of Transplant and Cellular Therapy (ASTCT) Committee on Quality Outcomes. I am co-chair of the Center for International Blood and Marrow Transplant Research (CIBMTR) Infection and Immune Reconstitution Working Committee.

Additional Languages

Portuguese, Spanish

Clinical Interests

Hematopoietic stem cell transplantation for children and young adults with malignancy or hemoglobinopathies

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Cancer and Blood Diseases, Bone Marrow Transplantation BMT, Cardio-Oncology

My Locations

My Education

BS: Weber State University, Ogden, UT, 2003.

MD: University of Utah, Salt Lake City, UT, 2007.

MSc: University of Cincinnati, Cincinnati, OH, 2014.

Residency: Miami Children’s Hospital, Miami, FL, 2010.

Chief Residency: Miami Children’s Hospital, Miami, FL, 2011.

Fellowship: Cincinnati Children's Hospital, Cincinnati Ohio, 2014; Quality Scholar in Healthcare Transformation, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2014.

Certification: Pediatrics, 2010; Pediatric Hematology Oncology, 2015.

My Publications

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Goldsmith, SR; Abid, MB; Auletta, JJ; Bashey, A; Beitinjaneh, A; Castillo, P; Chemaly, RF; Chen, M; Ciurea, S; Dandoy, CE; et al. Blood. 2021; 137:3291-3305.

Rapid cardiac MRI protocol for cardiac assessment in paediatric and young adult patients undergoing haematopoietic stem cell transplant: a feasibility study. Ryan, TD; Moore, RA; Lang, SM; Khoury, P; Dandoy, CE; Davies, SM; Taylor, MD. Cardiology in the Young. 2021; 1-6.

Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes. Luebbering, N; Abdullah, S; Lounder, D; Lane, A; Dole, N; Rubinstein, J; Hewison, M; Gloude, N; Jodele, S; Perentesis, KM R; et al. Haematologica. 2021; 106:1321-1329.

Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. Khandelwal, P; Yeh, RF; Yu, L; Lane, A; Dandoy, CE; El-Bietar, J; Davies, SM; Grimley, MS. Transplantation. 2021; 105:891-896.

Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis. Emberesh, M; Rubinstein, JD; Young, J; Benoit, SW; Dandoy, CE; Weiss, BD. Pediatric Blood and Cancer. 2021; 68.

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Sharma, A; Bhatt, NS; St Martin, A; Abid, MB; Bloomquist, J; Chemaly, RF; Dandoy, C; Gauthier, J; Gowda, L; Perales, MA; et al. The Lancet Haematology. 2021; 8:e185-e193.

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. Bona, K; Brazauskas, R; He, N; Lehmann, L; Abdel-Azim, H; Ahmed, IA; Al-Homsi, AS; Aljurf, M; Arnold, SD; Badawy, SM; et al. Blood. 2021; 137:556-568.

A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Dandoy, CE; Rotz, S; Alonso, PB; Klunk, A; Desmond, C; Huber, J; Ingraham, H; Higham, C; Dvorak, CC; Duncan, C; et al. Blood Advances. 2021; 5:1-11.

The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation. Laskin, BL; Denburg, MR; Furth, SL; Moatz, T; Altrich, M; Kleiboeker, S; Lutzko, C; Zhu, X; Blackard, JT; Jodele, S; et al. Clinical Infectious Diseases. 2020; 71:3044-3054.

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. Algwaiz, G; Aljurf, M; Koh, M; Horowitz, MM; Ljungman, P; Weisdorf, D; Saber, W; Kodera, Y; Szer, J; Jawdat, D; et al. Biology of Blood and Marrow Transplantation. 2020; 26:2181-2189.